Corebridge Financial Inc. Has $913,000 Stake in Alignment Healthcare, Inc. $ALHC

Corebridge Financial Inc. reduced its holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 1.5% during the 1st quarter, Holdings Channel reports. The institutional investor owned 49,035 shares of the company’s stock after selling 726 shares during the quarter. Corebridge Financial Inc.’s holdings in Alignment Healthcare were worth $913,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ALHC. MCF Advisors LLC increased its stake in Alignment Healthcare by 87.6% in the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after buying an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new stake in Alignment Healthcare in the 1st quarter valued at $42,000. Amalgamated Bank increased its stake in Alignment Healthcare by 21.6% in the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock valued at $65,000 after buying an additional 616 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after buying an additional 6,286 shares during the last quarter. Finally, Voloridge Investment Management LLC acquired a new stake in Alignment Healthcare in the 4th quarter valued at $189,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ALHC has been the topic of several recent research reports. Wall Street Zen lowered shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday, August 10th. Zacks Research upgraded shares of Alignment Healthcare to a “hold” rating in a research note on Friday, August 8th. Barclays upgraded shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and lifted their price target for the company from $9.00 to $13.00 in a research note on Thursday, July 31st. Stephens upgraded shares of Alignment Healthcare to a “strong-buy” rating in a research note on Monday, June 2nd. Finally, KeyCorp upgraded shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price objective on the stock in a research note on Monday, August 25th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $18.83.

Alignment Healthcare Stock Down 2.7%

Alignment Healthcare stock opened at $15.86 on Friday. The firm has a market capitalization of $3.14 billion, a PE ratio of -56.64 and a beta of 1.17. The company’s 50-day moving average is $14.18 and its 200-day moving average is $15.42. Alignment Healthcare, Inc. has a fifty-two week low of $8.65 and a fifty-two week high of $21.06. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.14. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. Alignment Healthcare’s revenue for the quarter was up 49.0% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Sell-side analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Insider Buying and Selling at Alignment Healthcare

In related news, insider Hyong Kim sold 24,800 shares of Alignment Healthcare stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $16.00, for a total transaction of $396,800.00. Following the completion of the sale, the insider owned 447,367 shares of the company’s stock, valued at approximately $7,157,872. The trade was a 5.25% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Christopher J. Joyce sold 15,491 shares of Alignment Healthcare stock in a transaction dated Thursday, July 31st. The stock was sold at an average price of $16.01, for a total transaction of $248,010.91. Following the sale, the insider directly owned 374,531 shares of the company’s stock, valued at $5,996,241.31. The trade was a 3.97% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 636,185 shares of company stock worth $9,235,468 in the last ninety days. Insiders own 7.00% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.